A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin.
暂无分享,去创建一个
N. Mulder | E. de Vries | D. Sleijfer | D. Uges | P. Willemse | P. Postmus | J. Greidanus | M. Nieweg | D. Schipper
[1] E. Zocchi,et al. Encapsulation of adriamycin in human erythrocytes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[2] R. J. Cersosimo,et al. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] C. Haanen,et al. Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography. , 1985, Cytometry.
[4] T. Demeester,et al. Phase I trial of an implanted battery-powered, programmable drug delivery system for continuous doxorubicin administration. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] F. Ganzina. 4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data. , 1983, Cancer treatment reviews.
[6] M. Sack,et al. Clinical evaluation of long-term, continuous-infusion doxorubicin. , 1983, Cancer treatment reports.
[7] F. Pannuti,et al. Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases. , 1982, Cancer treatment reports.
[8] S. Shackney,et al. Increased relative effectiveness of doxorubicin against slowly proliferating sarcoma 180 cells after prolonged drug exposure. , 1982, Cancer treatment reports.
[9] S. Wallace,et al. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. , 1982, Annals of internal medicine.
[10] M. Shah,et al. An effective low‐dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patients , 1980, Cancer.
[11] S. Garattini,et al. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice. , 1978, Cancer treatment reports.
[12] A. Weiss,et al. Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. , 1976, Cancer treatment reports.
[13] T. Vree,et al. Rapid quantitative determination of seven anthracyclines and their hydroxy metabolites in body fluids. , 1984, Journal of chromatography.
[14] D. Philips,et al. Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .
[16] S. Riegelman,et al. Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion. , 1970, Journal of pharmaceutical sciences.